Literature DB >> 6651484

Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results.

S Slopek, I Durlakowa, B Weber-Dabrowska, A Kucharewicz-Krukowska, M Dabrowski, R Bisikiewicz.   

Abstract

One hundred and thirty eight septic cases were treated with specific bacteriophages. According to the International Classification of the Diseases (WHO, 1977), the treated cases were divided to 9 categories. Nearly all cases were long-term infections with antibiotic resistant organisms. Only specific bacteriophages were used in association with several types of surgical procedure. The technique of treatment is described. In 129 (93.5%) cases the results were good, in 9 (6.5%) cases local improvement was observed. It is concluded that bacteriophage therapy may be helpful in the treatment of long-term suppurative infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651484

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  37 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  The use of bacteriophages in eliminating polyresistant strains of Staphylococcus aureus and Streptococcus agalactiae.

Authors:  Z Brnáková; J Farkasovská; A Godány
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

4.  Bacteriophage therapy.

Authors:  B Dixon
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-02

5.  Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.

Authors:  P Barrow; M Lovell; A Berchieri
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

6.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

7.  Nonconventional Therapeutics against Staphylococcus aureus.

Authors:  Caroline M Grunenwald; Monique R Bennett; Eric P Skaar
Journal:  Microbiol Spectr       Date:  2018-11

8.  Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage.

Authors:  Steven Hagens; André Habel; Uwe von Ahsen; Alexander von Gabain; Udo Bläsi
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis--case report.

Authors:  S Letkiewicz; R Miedzybrodzki; W Fortuna; B Weber-Dabrowska; A Górski
Journal:  Folia Microbiol (Praha)       Date:  2009-11-24       Impact factor: 2.099

10.  A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses.

Authors:  Ryszard Miedzybrodzki; Wojciech Fortuna; Beata Weber-Dabrowska; Andrzej Górski
Journal:  Clin Exp Med       Date:  2009-04-07       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.